Dentons Advises Biofarm and Its Majority Shareholders on Landmark Acquisition by Polpharma Through Voluntary Public Takeover Offer
July 24, 2026
July 24, 2026
WASHINGTON, July 24 -- Dentons, a law firm, issued the following news:
* * *
Dentons advises Biofarm and its majority shareholders on landmark acquisition by Polpharma through voluntary public takeover offer
Bucharest/Budapest--Global law firm Dentons has advised Biofarm S.A., a leading Romanian pharmaceutical company listed on the Bucharest Stock Exchange, and its majority shareholders, Longshield Investment Group S.A. and Lion Capital S.A., on the acquisi . . .
* * *
Dentons advises Biofarm and its majority shareholders on landmark acquisition by Polpharma through voluntary public takeover offer
Bucharest/Budapest--Global law firm Dentons has advised Biofarm S.A., a leading Romanian pharmaceutical company listed on the Bucharest Stock Exchange, and its majority shareholders, Longshield Investment Group S.A. and Lion Capital S.A., on the acquisi . . .
